Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial
The purpose of this study is to assess the clinical improvement by partial seizures
 reduction, safety and tolerability of subjects having partial epilepsy related to the
 adjunction of pregabalin BID (75 to 300mg day titration, BID) to existing standard AED
 (Antiepileptic drugs).
This study was terminated on 17 March 2009 due to delayed enrollment. The decision to
 terminate the trial was not based on any safety concerns, but rather on timelines and the
 difficulty in enrolling patients in this open label, single group study.
Inclusion Criteria:

 -  Male or Female who are diagnosed of partial seizure (simple partial, complex partial,
 partial seizure secondarily generalized) as defined in the international league of
 epilepsy classification of seizure.

 Exclusion Criteria:

 -  Patients having a treatable cause of seizure, currently receiving vigabatrin, having a
 progressive neurological or systemic disorder.